1. Home
  2. SW vs UTHR Comparison

SW vs UTHR Comparison

Compare SW & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smurfit WestRock plc Ordinary Shares

SW

Smurfit WestRock plc Ordinary Shares

HOLD

Current Price

$39.70

Market Cap

20.9B

Sector

N/A

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$570.68

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SW
UTHR
Founded
1934
1996
Country
Ireland
United States
Employees
97000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9B
25.1B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
SW
UTHR
Price
$39.70
$570.68
Analyst Decision
Strong Buy
Buy
Analyst Count
12
14
Target Price
$53.58
$567.57
AVG Volume (30 Days)
4.6M
354.1K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
4.56%
N/A
EPS Growth
N/A
13.07
EPS
N/A
27.86
Revenue
N/A
$1,483,300,000.00
Revenue This Year
$4.43
$6.39
Revenue Next Year
$3.13
$14.18
P/E Ratio
$38.98
$20.87
Revenue Growth
N/A
2.38
52 Week Low
$32.73
$272.18
52 Week High
$52.65
$607.89

Technical Indicators

Market Signals
Indicator
SW
UTHR
Relative Strength Index (RSI) 47.08 52.89
Support Level $36.00 $560.16
Resistance Level $44.20 $593.65
Average True Range (ATR) 1.47 13.40
MACD -0.17 -2.30
Stochastic Oscillator 44.35 29.11

Price Performance

Historical Comparison
SW
UTHR

About SW Smurfit WestRock plc Ordinary Shares

Smurfit WestRock PLC manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. operates a vertically integrated system supplying wood and recovered fiber to produce various grades of board, which are then converted into packaging products. Its main packaging categories include corrugated containers and consumer packaging, with additional products such as solidboard, kraft paper, graphic board, paper sacks, and bag-in-box packaging. The company's geographical segments include North America (including the U.S., Canada and Mexico), Europe, the Middle East and Africa and Asia-Pacific, and Latin America. The majority of the company's revenue is derived from product sales in the North American region.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: